Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Seribantumab (DB11857)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01447706A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian CancersTreatment